AVENUE SOLUTIONS

Lobbying for ILLUMINA, INC. · Sequencing and array-based solutions for genetic research, clinical and applied markets

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $60,000.00 income · posted Jul 20, 2026

Bills named in this filing 1

Lobbying activity 2

Health Issues

Issues related to genomic sequencing; H.R. 7118, Genomic Answers for Childrens Health Act of 2026

Trade (domestic/foreign)

General trade issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.